A pilot, open study to assess efficacy and safety of ON-01910 (rigosertib) in patients with recessive dystrophic epidermolysis bullosa associated locally advanced/metastatic squamous cell carcinoma
Publication/Presentation Date
5-2023
Volume
41
Issue
16
Published In/Presented At
Disciplines
Medicine and Health Sciences
Department(s)
Patient Care Services / Nursing
Document Type
Article
COinS